Search the Newsreel

Pharmacy giant Bristol Myers Squibb to build $2.3B Houston factory

Bristol Myers Squibb has chosen Houston, Texas, as the location for its new state-of-the-art manufacturing facility. This 60,000-square-foot site represents a $2.3 billion investment and is projected to create 500 skilled jobs in Generation Park. Construction is set to begin next year, with the …

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A federal appeals court has reinstated a $6.7 billion lawsuit against Bristol Myers Squibb, brought by UMB Bank on behalf of former Celgene shareholders. The suit alleges Bristol Myers deliberately delayed FDA approvals for three drugs, including the cancer therapy Breyanzi, to avoid payouts …

Cytokinetics sues Bristol-Myers in patent case (CYTK:NASDAQ)

Cytokinetics has filed a lawsuit against Bristol-Myers Squibb and its acquisition MyoKardia. The suit aims to prevent a potential patent infringement case concerning Cytokinetics' heart disease treatment, Myqorzo (aficamten). The dispute involves U.S. Patent No. 12,616,697.

Die Bristol-Myers-Squibb-Aktie steigt nach Konsensstärke und solider Dividendenrendite

Bristol Myers Squibb (BMY) Invierte En Houston Y Reabre El Debate Sobre Su Valoración

Brisanet sobe 6% após lucro de R$ 26 milhões no 2º trimestre

Why Bristol Myers Squibb (BMY) Is Back In The Spotlight

Is Bristol Myers’ US$2.3 Billion Houston Manufacturing Campus Altering The Investment Case For BMY?

Bristol Myers Squibb recently announced it will invest about US$2.30 billion in a new 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, Texas, expected to support production of small molecules, biologics, and antibody-drug conjugates while creating nearly 500 skilled jobs and about …

Wedge Capital Management L L P NC Raises Stock Position in Bristol Myers Squibb Company $BMY

Handelsbanken Fonder AB Sells 446,938 Shares of Bristol Myers Squibb Company $BMY

Assenagon Asset Management S.A. Boosts Holdings in Bristol Myers Squibb Company $BMY

Brisanet (BRST3): trimestre decente, com mobile impulsionando o crescimento

Bristow Group (VTOL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Senior Manager of Investor Relations and Financial Reporting - Redeate TilahunPresident and Chief Executive Officer - Christopher BradshawSenior Vice President and Chief Financial Officer - Jennifer Whalen TAKEAWAYS …

AstraZeneca held talks with Bristol-Myers through spring, summer - FT

AstraZeneca reportedly engaged in discussions with Bristol-Myers Squibb over the spring and summer regarding a potential acquisition. The talks were centered around AstraZeneca purchasing Bristol-Myers in a mostly stock-based deal at a premium.

Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors

Reports recently surfaced regarding a potential merger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb, causing significant industry speculation. Although a senior source reportedly debunked these rumors, the prospect of such a large-scale merger between two strong performers raised questions about its strategic rationale …

News | Bristol Myers Squibb plans $2.3 billion Houston campus

Bristol Myers Squibb announced plans for a $2.3 billion, 600,000-square-foot campus in Houston's Generation Park, expected to create nearly 500 skilled jobs by 2030. This investment is part of a larger $40 billion commitment to U.S. operations, aiming to boost domestic manufacturing and reduce …

Is Schrödinger (SDGR) Undervalued Following Its Profit Turn And Bristol Myers Squibb Deal?

Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston

Bristol Myers Squibb has announced a $2.3 billion investment to build a manufacturing campus in Houston, significantly increasing its initial estimate of $1 billion. The facility, expected to employ nearly 500 people and be completed by 2030, will produce small molecules, biologics, and antibody-drug …

BMS Chooses Houston for $2.3B Manufacturing Facility

Bristol Myers Squibb (BMS) has selected Houston as the location for a new $2.3 billion multi-modal manufacturing campus. This facility, part of BMS's $40 billion U.S. investment, will support the production of various treatments including small molecules, biologics, and ADCs. The campus aims to …

Pharma giant bets $2.3B on massive new Houston campus

Bristol Myers Squibb has chosen Houston for a new $2.3 billion manufacturing campus at Generation Park. This massive 600,000-square-foot facility is expected to create nearly 500 skilled jobs and approximately 2,000 indirect jobs during its construction phase. The investment is part of the company's …

New Bristol Myers Squibb facility coming to Generation Park

Global biopharmaceutical company Bristol Myers Squibb is set to establish a new pharmaceutical manufacturing campus in the Houston area, specifically near Generation Park. FOX 26's Karys Belger reported on this development. The facility will mark a significant expansion for the company in the region.

Bristol Myers Squibb to expand in Harris County

The article states that Bristol Myers Squibb plans to expand its operations in Harris County. No further details are provided regarding the nature or scope of this expansion.

BRISTOL-MYERS SQUIBB AKTIE: AI-Analysen, Prognose & Kursziel

Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas

Bristol Myers Squibb is investing $2.3 billion to construct a new drug manufacturing campus in Houston, Texas, creating nearly 500 initial jobs and 2,000 construction jobs. The 600,000-square-foot facility at Generation Park will produce various next-generation medicines. Texas Governor Greg Abbott praised the investment, …

Bristol Myers Squibb to build $2.3 billion Houston campus

Bristol Myers Squibb announced Monday it will build a $2.3 billion drug manufacturing campus in Houston, Texas, part of the company's broader $40 billion commitment to invest in the United States over five years. The roughly 600,000-square-foot campus will be located at Generation Park, …

Bristol Myers Squibb selects Generation Park for new $2.3B manufacturing campus

Bristol Myers Squibb has chosen Generation Park in northeast Houston for its new $2.3 billion manufacturing campus, a project anticipated to create nearly 500 jobs directly and 2,000 construction jobs. The 600,000-square-foot facility will produce various medicines, supporting the company's $40 billion investment in …

Bristol Myers Squibb opening pharmaceutical manufacturing campus near Houston

Bristol Myers Squibb is establishing a new $2.3 billion pharmaceutical manufacturing campus in Generation Park near Houston, expected to create nearly 500 new permanent jobs and 2,000 construction jobs. This marks the second major pharmaceutical investment in the area, following Eli Lilly's plans for …

Bristol Myers To Invest $2.3 Bln In Houston Manufacturing Campus; To Create 500 Skilled Jobs

(RTTNews) - Bristol Myers Squibb (BMY) announced Monday an investment of approximately $2.3 billion in the U.S., while selecting Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus to accelerate the delivery of next-generation medicines to patients. The approximately 600,000 square …

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb announced a $2.3 billion investment to construct a new manufacturing facility in Houston, Texas, creating nearly 500 skilled jobs and approximately 2,000 construction jobs. This initiative is part of the company's $40 billion commitment to U.S. investments and aligns with a …

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

New State-of-the-Art Facility Will Create Nearly 500 Skilled Jobs and Accelerate the Delivery of Next-Generation Medicines Investment Furthers BMS' $40 Billion Commitment to American Innovation, Manufacturing and Economic Growth PRINCETON, N.J., August 10, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, …

BioNTech Aktie: 613 Millionen von Bristol Myers Squibb erwartet

Weekly Recap: Merger talks with Bristol Myers and Imjudo launch in China

AstraZeneca (AZN) has been involved in preliminary merger discussions with Bristol Myers Squibb, which reportedly led to a dip in AZN's share price. Concurrently, AstraZeneca is focusing on organic growth, marked by the launch of its cancer drug Imjudo in China, a new biologics …

Bristol Myers Squibb Invests $2.3B in New Houston Pharma Facility

Bristol Myers Squibb is investing $2.3 billion to construct a 600,000-square-foot manufacturing facility at Generation Park in northeast Houston, expected to create nearly 500 jobs. This significant investment further establishes Houston as a leading hub for life sciences and advanced manufacturing, following similar large-scale …

Bristow Group Inc. (NYSE:VTOL) Pays A US$0.125 Dividend In Just Four Days

Bristow Group Inc. (NYSE:VTOL) will pay a dividend of US$0.125 per share in four days, with the ex-dividend date set for August 15th. The company's dividend yield is 2.5%, based on its last four dividend payments totaling US$0.50. While the dividend appears stable, investors …

Bristow Group Q2 Earnings Call Highlights

Vertical's Valo Launch: A Commercial Leap Disguised as a Dip Bristow Group (NYSE:VTOL) affirmed its full-year 2026 adjusted EBITDA outlook after reporting higher sequential revenue and profitability in the second quarter, while outlining the recently completed acquisition of Berry Aviation and plans to sell …

Bristol-Myers-Squibb-Aktie bleibt nach Zahlen und Pipeline-Kurs im Blick